Novartis AG is 82.6x more valuable than NewAmsterdam Pharma Company N.V. by market capitalization ($283.13 B vs $3.43 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | NAMS | NVS |
|---|---|---|
| Market cap | $3.43 B | $283.13 B |
| US-listed rank | #1703 | #47 |
| Revenue (latest FY) | $22.50M | - |
| Net income (latest FY) | -$203.00M | - |
| Net margin | -902.1% | - |
| SEC filings | 386 | 947 |
Novartis AG is 82.6x more valuable than NewAmsterdam Pharma Company N.V. by market capitalization ($283.13 B vs $3.43 B).
Full pages: NewAmsterdam Pharma Company N.V. and Novartis AG, or browse the full rankings.